Role of oxidative DNA damage in mitochondrial dysfunction and Huntington's disease pathogenesis
- PMID: 23602907
- PMCID: PMC3722255
- DOI: 10.1016/j.freeradbiomed.2013.04.017
Role of oxidative DNA damage in mitochondrial dysfunction and Huntington's disease pathogenesis
Abstract
Huntington's disease (HD) is a neurodegenerative disorder with an autosomal dominant expression pattern and typically a late-onset appearance. HD is a movement disorder with a heterogeneous phenotype characterized by involuntary dance-like gait, bioenergetic deficits, motor impairment, and cognitive and psychiatric deficits. Compelling evidence suggests that increased oxidative stress and mitochondrial dysfunction may underlie HD pathogenesis. However, the exact mechanisms underlying mutant huntingtin-induced neurological toxicity remain unclear. The objective of this paper is to review recent literature regarding the role of oxidative DNA damage in mitochondrial dysfunction and HD pathogenesis.
Keywords: 3-NPA; 3-nitropropionic acid; 7,8-dihydro-8-oxoguanine-DNA glycosylase; 8-OHdG; 8-hydroxydeoxyguanosine; AP; ARE; ATM; ATR; BER; DNA repair; FEN1; HD; Huntington’s disease; MMR; Mitochondrial DNA; Mitochondrial bioenergetics; Mitochondrial dysfunction; NF-E2-related factor 2; Nrf2; OGG1; Oxidative stress; PGC-1α; POL β; PPARγ; ROS; Rad3-related kinase; Sirt; antioxidant response element; apurinic/apyrimidinic; ataxia telangiectasia mutated kinase; base excision repair; flap endonuclease 1; mismatch repair; peroxisome proliferator-activated receptor-γ; peroxisome proliferator-activated receptor-γ coactivator-1 α; polymerase beta; reactive oxygen species; sirtuins.
Copyright © 2013 Elsevier Inc. All rights reserved.
Figures


Similar articles
-
Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington's disease.Free Radic Biol Med. 2012 Oct 1;53(7):1478-88. doi: 10.1016/j.freeradbiomed.2012.06.008. Epub 2012 Jun 16. Free Radic Biol Med. 2012. PMID: 22709585 Free PMC article.
-
PGC-1α, mitochondrial dysfunction, and Huntington's disease.Free Radic Biol Med. 2013 Sep;62:37-46. doi: 10.1016/j.freeradbiomed.2013.04.016. Epub 2013 Apr 19. Free Radic Biol Med. 2013. PMID: 23602910 Free PMC article. Review.
-
The role of mitochondrial dysfunction in Huntington's disease: Implications for therapeutic targeting.Biomed Pharmacother. 2025 Feb;183:117827. doi: 10.1016/j.biopha.2025.117827. Epub 2025 Jan 23. Biomed Pharmacother. 2025. PMID: 39854819 Review.
-
Huntingtin is a scaffolding protein in the ATM oxidative DNA damage response complex.Hum Mol Genet. 2017 Jan 15;26(2):395-406. doi: 10.1093/hmg/ddw395. Hum Mol Genet. 2017. PMID: 28017939
-
Stoichiometry of base excision repair proteins correlates with increased somatic CAG instability in striatum over cerebellum in Huntington's disease transgenic mice.PLoS Genet. 2009 Dec;5(12):e1000749. doi: 10.1371/journal.pgen.1000749. Epub 2009 Dec 4. PLoS Genet. 2009. PMID: 19997493 Free PMC article.
Cited by
-
The chicken or the egg: mitochondrial dysfunction as a cause or consequence of toxicity in Huntington's disease.Mech Ageing Dev. 2017 Jan;161(Pt A):181-197. doi: 10.1016/j.mad.2016.09.003. Epub 2016 Sep 12. Mech Ageing Dev. 2017. PMID: 27634555 Free PMC article. Review.
-
Succinobucol, a Lipid-Lowering Drug, Protects Against 3-Nitropropionic Acid-Induced Mitochondrial Dysfunction and Oxidative Stress in SH-SY5Y Cells via Upregulation of Glutathione Levels and Glutamate Cysteine Ligase Activity.Mol Neurobiol. 2016 Mar;53(2):1280-1295. doi: 10.1007/s12035-014-9086-x. Epub 2015 Jan 27. Mol Neurobiol. 2016. PMID: 25619973
-
Retinal mitochondrial DNA mismatch repair in the development of diabetic retinopathy, and its continued progression after termination of hyperglycemia.Invest Ophthalmol Vis Sci. 2014 Sep 23;55(10):6960-7. doi: 10.1167/iovs.14-15020. Invest Ophthalmol Vis Sci. 2014. PMID: 25249609 Free PMC article.
-
MUTYH Deficiency Is Associated with Attenuated Pulmonary Fibrosis in a Bleomycin-Induced Model.Oxid Med Cell Longev. 2020 Oct 16;2020:4828256. doi: 10.1155/2020/4828256. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 33149810 Free PMC article.
-
Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases.Arch Toxicol. 2024 Mar;98(3):579-615. doi: 10.1007/s00204-023-03660-8. Epub 2024 Jan 24. Arch Toxicol. 2024. PMID: 38265475 Free PMC article. Review.
References
-
- Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE, Watkins PC, Ottina K, Wallace MR, Sakaguchi AY, et al. A polymorphic DNA marker genetically linked to Huntington’s disease. Nature. 1983;306:234–238. - PubMed
-
- Huntington’s; Disease; Collaborative; Research; Group. A novel gene containing a trinucleotide repeat that is unstable on Hntington’s Disease chromosomes. Cell. 1993;72:971–983. - PubMed
-
- Andrew S, Theilmann J, Almqvist E, Norremolle A, Lucotte G, Anvret M, Sorensen S, Turpin J, Hayden M. DNA analysis of distinct populations suggests multiple origins for the mutation causing Huntington disease. Clin Genet. 1993;43:286–294. - PubMed
-
- Duyao M, Ambrose C, Myers R, Novelletto A, Persichetti F, Frontali M, Folstein S, Ross C, Franz M, Abbott M. Trinucleotide repeat length instability and age of onset in Huntington’s disease. Nat Genet. 1993;673–676:673–676. - PubMed
-
- Snell R, MacMillan J, Cheadle J, Fenton I, Lazarou L, Davies P, MacDonald M, Gusella J, Harper P, Shaw D. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington’s disease. Nat Genet. 1993;4:393–397. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous